These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
397 related items for PubMed ID: 12358261
21. Dopaminergic control of renal tubular function in patients with compensated cirrhosis. Sansoè G, Ferrari A, Baraldi E, Castellana CN, Biava A, Silvano S, Rosina F, Bonardi L, Manenti F. Dig Dis Sci; 2002 Feb; 47(2):392-400. PubMed ID: 11855557 [Abstract] [Full Text] [Related]
22. Renal hemodynamics and the renin-angiotensin system in cirrhosis. Aliaga L, Zozaya JM, Quiroga J, Richter JA, Prieto J. Rev Esp Fisiol; 1989 Feb; 45 Suppl():371-5. PubMed ID: 2701770 [Abstract] [Full Text] [Related]
23. Hyperinsulinemia in preascitic cirrhosis: effects on systemic and renal hemodynamics, sodium homeostasis, forearm blood flow, and sympathetic nervous activity. Wong F, Logan A, Blendis L. Hepatology; 1996 Mar; 23(3):414-22. PubMed ID: 8617419 [Abstract] [Full Text] [Related]
24. Renal function and functional reserve in healthy elderly individuals. Esposito C, Plati A, Mazzullo T, Fasoli G, De Mauri A, Grosjean F, Mangione F, Castoldi F, Serpieri N, Cornacchia F, Dal Canton A. J Nephrol; 2007 Mar; 20(5):617-25. PubMed ID: 17918149 [Abstract] [Full Text] [Related]
25. [Sympathetic nervous activity in cirrhosis: the relationship between peripheral hemodynamics and renal function changes]. Fernández Rodríguez CM, Prieto J, Quiroga J, Prada I, Rodríguez D, Pereira S, Pallarés A, Andrade A, Penas J. Gastroenterol Hepatol; 1996 Apr; 19(4):194-8. PubMed ID: 8665356 [Abstract] [Full Text] [Related]
26. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension. Bech JN, Nielsen EH, Pedersen RS, Svendsen KB, Pedersen EB. Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742 [Abstract] [Full Text] [Related]
27. Plasma substance P levels in patients with liver cirrhosis: relationship to systemic and portal hemodynamics. Lee FY, Lin HC, Tsai YT, Chang FY, Lu RH, Hou MC, Li CP, Chu CJ, Wang SS, Lee SD. Am J Gastroenterol; 1997 Nov; 92(11):2080-4. PubMed ID: 9362197 [Abstract] [Full Text] [Related]
28. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide. Semplicini A, Ceolotto G, Sartori M, Maresca A, Baritono E, De Toni R, Paparella I, Calò L. J Nephrol; 2002 Nov; 15(5):489-96. PubMed ID: 12455714 [Abstract] [Full Text] [Related]
29. Increased renin release by exogenous prostaglandin E1 in liver cirrhosis with and without ascites. Uemasu J, Kawasaki H, Hirayama C. Horm Metab Res; 1988 May; 20(5):302-5. PubMed ID: 3042580 [Abstract] [Full Text] [Related]
30. Nitric oxide synthase inhibition does not improve renal function in cirrhotic patients with ascites. Thiesson HC, Skøtt O, Jespersen B, Schaffalitzky de Muckadell OB. Am J Gastroenterol; 2003 Jan; 98(1):180-6. PubMed ID: 12526955 [Abstract] [Full Text] [Related]
31. Glomerular filtration rate measurement in cirrhotic patients with renal failure. Roy L, Legault L, Pomier-Layrargues G. Clin Nephrol; 1998 Dec; 50(6):342-6. PubMed ID: 9877106 [Abstract] [Full Text] [Related]
32. Does endothelin-1 play a role in the renal function of cirrhotic patients? Bruno CM, D'Amico R, Ierna D, Neri S. Panminerva Med; 1998 Sep; 40(3):196-8. PubMed ID: 9785916 [Abstract] [Full Text] [Related]
33. Daily profile of circulating C-type natriuretic peptide in pre-ascitic cirrhosis and in normal subjects: relationship with renal function. Zambruni A, Trevisani F, Gülberg V, Caraceni P, Domenicali M, Cantarini MC, Cappa FM, Di Micoli A, Magini G, Labate-Morselli AM, Gerbes AL, Bernardi M. Scand J Gastroenterol; 2007 May; 42(5):642-7. PubMed ID: 17454886 [Abstract] [Full Text] [Related]
34. Dendroaspis natriuretic peptide in hepatic cirrhosis. Fábrega E, Crespo J, Rivero M, Casafont F, Castro B, García-Unzueta MT, Amado JA, Pons-Romero F. Am J Gastroenterol; 2001 Sep; 96(9):2724-9. PubMed ID: 11569702 [Abstract] [Full Text] [Related]
35. Renal function and structure in subacute hepatic failure. Bal C, Longkumer T, Patel C, Gupta SD, Acharya SK. J Gastroenterol Hepatol; 2000 Nov; 15(11):1318-24. PubMed ID: 11129228 [Abstract] [Full Text] [Related]
36. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Wong F, Pantea L, Sniderman K. Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086 [Abstract] [Full Text] [Related]
37. The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites. Kalambokis G, Economou M, Fotopoulos A, Al Bokharhii J, Pappas C, Katsaraki A, Tsianos EV. Am J Gastroenterol; 2005 Apr; 100(4):879-85. PubMed ID: 15784036 [Abstract] [Full Text] [Related]
38. Plasma adrenomedullin levels in patients with hepatic cirrhosis. Fábrega E, Casafont F, Crespo J, de la Peña J, San Miguel G, de las Heras G, García-Unzueta MT, Amado JA, Pons-Romero F. Am J Gastroenterol; 1997 Oct; 92(10):1901-4. PubMed ID: 9382062 [Abstract] [Full Text] [Related]
39. Effect of rofecoxib on the glomerular filtration rate, proteinuria and the renin-angiotensin-aldosterone system in elderly subjects with chronic renal impairment. Horackova M, Schück O, Komers R, Charvat J, Teplan V, Kvapil M. Int J Clin Pharmacol Ther; 2005 Sep; 43(9):413-9. PubMed ID: 16163893 [Abstract] [Full Text] [Related]
40. Lack of renal effects of fish oil administration in patients with advanced cirrhosis and impaired glomerular filtration. Badalamenti S, Salerno F, Salmeron JM, Lorenzano E, Rimola A, Ginés P, Jimenez W, Graziani G, Arroyo V, Rodes J, Ponticelli C. Hepatology; 1997 Feb; 25(2):313-6. PubMed ID: 9021940 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]